{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:53:24Z","timestamp":1777625604332,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T00:00:00Z","timestamp":1643932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T00:00:00Z","timestamp":1643932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81601246"],"award-info":[{"award-number":["81601246"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31872846"],"award-info":[{"award-number":["31872846"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801530"],"award-info":[{"award-number":["81801530"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gestational trophoblastic disease (GTD) usually affects young women of childbearing age. After treatment for GTD, 86% of women wish to achieve pregnancy. On account of the impacts of GTD and treatments as well as patient anxiety, large numbers of couples turn to assisted reproductive technology (ART), especially in vitro fertilization\/intracytoplasmic sperm injection (IVF\/ICSI). But few studies have investigated whether a history of GTD affects the outcomes of IVF\/ICSI in secondary infertile patients and how it occurs. We investigate whether a history of GTD affects the IVF\/ICSI outcomes and the live birth rates in women with secondary infertility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study enrolled 176 women with secondary infertility who underwent IVF\/ICSI treatment at the reproductive medical center of Nanjing Drum Tower Hospital from January 1, 2016, to December 31, 2020. Participants were divided into the GTD group (44 women with GTD history) and control group (132 women without GTD history matched from 8318 secondary infertile women). The control group and the study group were matched at a ratio of 3:1 according to patient age, infertility duration, number of cycles and body mass index (BMI). We assessed retrieved oocytes and high-grade embryos, biochemical pregnancy, miscarriage, ectopic pregnancy, gestational age at delivery, delivery mode and live birth rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result(s)<\/jats:title>\n                    <jats:p>\n                      We found a significantly reduced live-birth rate (34.1% vs 66.7%) associated with IVF\/ICSI cycles in patients with a GTD history compared to those without a GTD history. The biochemical pregnancy and miscarriage rates of the GTD group were slightly higher than those of the control group. In addition, there was a difference in gestational age at delivery between the GTD and control groups (\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001) but no differences in the mode of delivery (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.267). Furthermore, the number of abandoned embryos in the GTD group was greater than that in the control group (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.018), and the number of good-quality embryos was less than that in the control group (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.019). The endometrial thickness was thinner (\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001) in the GTD group. Immunohistochemistry (IHC) showed abnormal endometrial receptivity in the GTD group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion(s)<\/jats:title>\n                    <jats:p>The GTD history of patients undergoing IVF\/ICSI cycles had an impact on the live-birth rate and gestational age at delivery, which might result from the thinner endometrium and abnormal endometrial receptivity before embryo transfer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12958-022-00898-2","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T11:12:34Z","timestamp":1643973154000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association between gestational trophoblastic disease (GTD) history and clinical outcomes in in vitro fertilization\/intracytoplasmic sperm injection (IVF\/ICSI) cycles"],"prefix":"10.1186","volume":"20","author":[{"given":"Xinyu","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenyang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jidong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manlin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guijun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6613-1957","authenticated-orcid":false,"given":"Na","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,4]]},"reference":[{"issue":"3","key":"898_CR1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1136\/ijgc-2020-001784","volume":"31","author":"U Joneborg","year":"2021","unstructured":"Joneborg U, Coopmans L, van Trommel N, Seckl M, Lok CAR. Fertility and pregnancy outcome in gestational trophoblastic disease. Int J Gynecol Cancer. 2021;31(3):399\u2013411.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"898_CR2","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1016\/S1470-2045(17)30686-1","volume":"19","author":"J Ireson","year":"2018","unstructured":"Ireson J, Jones G, Winter MC, Radley SC, Hancock BW, Tidy JA. Systematic review of health-related quality of life and patient-reported outcome measures in gestational trophoblastic disease: a parallel synthesis approach. Lancet Oncol. 2018;19(1):e56\u201364.","journal-title":"Lancet Oncol"},{"key":"898_CR3","doi-asserted-by":"crossref","unstructured":"Di Mattei V, Mazzetti M, Perego G, Rottoli S, Mangili G, Bergamini A, et al. Psychological aspects and fertility issues of GTD. Best Pract Res Clin Obstet Gynaecol. 2021;74:53-66.","DOI":"10.1016\/j.bpobgyn.2020.10.007"},{"issue":"4","key":"898_CR4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s10815-018-1389-9","volume":"36","author":"M Nickkho-Amiry","year":"2019","unstructured":"Nickkho-Amiry M, Horne G, Akhtar M, Mathur R, Brison DR. Hydatidiform molar pregnancy following assisted reproduction. J Assist Reprod Genet. 2019;36(4):667\u201371.","journal-title":"J Assist Reprod Genet"},{"issue":"6","key":"898_CR5","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S1521-6934(03)00093-2","volume":"17","author":"E Garner","year":"2003","unstructured":"Garner E, Goldstein DP, Berkowitz RS, Wenzel L. Psychosocial and reproductive outcomes of gestational trophoblastic diseases. Best Pract Res Clin Obstetr Gynaecol. 2003;17(6):959\u201368.","journal-title":"Best Pract Res Clin Obstetr Gynaecol"},{"issue":"6","key":"898_CR6","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1046\/j.1471-0528.2003.02419.x","volume":"110","author":"C Lok","year":"2003","unstructured":"Lok C. Pregnancy after EMA\/CO for gestational trophoblastic disease: a report from The Netherlands. BJOG: Int J Obstetr Gynaecol. 2003;110(6):560\u20136.","journal-title":"BJOG: Int J Obstetr Gynaecol"},{"issue":"7","key":"898_CR7","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1093\/oxfordjournals.humrep.a019432","volume":"11","author":"L Pal","year":"1996","unstructured":"Pal L, Toth TL, Leykin L, Isaacson KB. High incidence of triploidy in in-vitro fertilized oocytes from a patient with a previous history of recurrent gestational trophoblastic disease. Hum Reprod. 1996;11(7):1529\u201332.","journal-title":"Hum Reprod"},{"issue":"2","key":"898_CR8","doi-asserted-by":"publisher","first-page":"e039122","DOI":"10.1136\/bmjopen-2020-039122","volume":"11","author":"H Yang","year":"2021","unstructured":"Yang H, Zheng C, Zheng Q, Xu H, Li X, Hao M, et al. Controlled ovarian hyperstimulation for poor ovarian responders undergoing in vitro fertilisation\/intracytoplasmic sperm injection: a protocol for systematic review and Bayesian network meta-analysis. BMJ Open. 2021;11(2):e039122.","journal-title":"BMJ Open"},{"issue":"5","key":"898_CR9","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.rbmo.2020.07.027","volume":"41","author":"X Hou","year":"2020","unstructured":"Hou X, Xing J, Shan H, Mei J, Sun Y, Yan G, et al. The effect of adenomyosis on IVF after long or ultra-long GnRH agonist treatment. Reprod BioMed Online. 2020;41(5):845\u201353.","journal-title":"Reprod BioMed Online"},{"key":"898_CR10","doi-asserted-by":"crossref","unstructured":"Taiyeb AM, Haji AI, Ibraheem ZO, Alsakkal GS. Pregnancy outcomes following different protocols of controlled ovarian hyperstimulation in couples undergoing intrauterine insemination. Clin Exp Pharmacol Physiol. 2021.","DOI":"10.1111\/1440-1681.13506"},{"issue":"3","key":"898_CR11","first-page":"316","volume":"18","author":"E Taerk","year":"2017","unstructured":"Taerk E, Hughes E, Greenberg C, Neal M, Amin S, Faghih M, et al. Controlled Ovarian Hyperstimulation with Intrauterine Insemination Is More Successful After r-hCG Administration Than Spontaneous LH Surge. J Reprod Infertil. 2017;18(3):316\u201322.","journal-title":"J Reprod Infertil"},{"issue":"6","key":"898_CR12","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1093\/humrep\/der037","volume":"26","author":"Alpha Scientists in Reproductive M, Embryology ESIGo","year":"2011","unstructured":"Alpha Scientists in Reproductive M, Embryology ESIGo. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod. 2011;26(6):1270\u201383.","journal-title":"Hum Reprod"},{"issue":"6","key":"898_CR13","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.rbmo.2011.02.001","volume":"22","author":"ASIR Medicine","year":"2011","unstructured":"Medicine ASIR, Embryology ESIG. Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Reprod BioMed Online. 2011;22(6):632\u201346.","journal-title":"Reprod BioMed Online"},{"issue":"5","key":"898_CR14","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/BF01133388","volume":"3","author":"JM Cummins","year":"1986","unstructured":"Cummins JM, Breen TM, Harrison KL, Shaw JM, Wilson LM, Hennessey JF. A formula for scoring human embryo growth rates in in vitro fertilization: its value in predicting pregnancy and in comparison with visual estimates of embryo quality. J In Vitro Fert Embryo Transf. 1986;3(5):284\u201395.","journal-title":"J In Vitro Fert Embryo Transf"},{"issue":"8","key":"898_CR15","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1093\/oxfordjournals.humrep.a136618","volume":"2","author":"F Puissant","year":"1987","unstructured":"Puissant F, Vanrysselberge M, Barlow P, Deweze J, Leroy F. Embryo Scoring as a Prognostic Tool in Ivf Treatment. Hum Reprod. 1987;2(8):705\u20138.","journal-title":"Hum Reprod"},{"issue":"1","key":"898_CR16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s12884-019-2543-9","volume":"19","author":"J Meng","year":"2019","unstructured":"Meng J, Zhu M, Shen W, Huang X, Sun H, Zhou J. Influence of surgical evacuation on pregnancy outcomes of subsequent embryo transfer cycle following miscarriage in an initial IVF cycle: a retrospective cohort study. BMC Pregnancy Childbirth. 2019;19(1):409.","journal-title":"BMC Pregnancy Childbirth"},{"key":"898_CR17","doi-asserted-by":"crossref","unstructured":"Fisher RA, Maher GJ. Genetics of gestational trophoblastic disease. Best Pract Res Clin Obstet Gynaecol. 2021;74:29-41.","DOI":"10.1016\/j.bpobgyn.2021.01.004"},{"issue":"11","key":"898_CR18","first-page":"A5082","volume":"62","author":"I Niemann","year":"2015","unstructured":"Niemann I, Vejerslev LO, Froding L, Blaakaer J, Maroun LL, Hansen ES, et al. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling. Dan Med J. 2015;62(11):A5082.","journal-title":"Dan Med J"},{"issue":"1","key":"898_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejogrb.2010.01.003","volume":"150","author":"D Williams","year":"2010","unstructured":"Williams D, Hodgetts V, Gupta J. Recurrent hydatidiform moles. Eur J Obstet Gynecol Reprod Biol. 2010;150(1):3\u20137.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"898_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.5653\/cerm.2017.44.1.40","volume":"44","author":"ES Sills","year":"2017","unstructured":"Sills ES, Obregon-Tito AJ, Gao H, McWilliams TK, Gordon AT, Adams CA, et al. Pathogenic variant in NLRP7 (19q13.42) associated with recurrent gestational trophoblastic disease: Data from early embryo development observed during in vitro fertilization. Clin Exp Reprod Med. 2017;44(1):40\u20136.","journal-title":"Clin Exp Reprod Med"},{"issue":"4","key":"898_CR21","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1093\/humupd\/dmu011","volume":"20","author":"A Kasius","year":"2014","unstructured":"Kasius A, Smit JG, Torrance HL, Eijkemans MJ, Mol BW, Opmeer BC, et al. Endometrial thickness and pregnancy rates after IVF: a systematic review and meta-analysis. Hum Reprod Update. 2014;20(4):530\u201341.","journal-title":"Hum Reprod Update"},{"issue":"6","key":"898_CR22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3109\/09513590.2015.1132304","volume":"32","author":"R Fang","year":"2016","unstructured":"Fang R, Cai L, Xiong F, Chen J, Yang W, Zhao X. The effect of endometrial thickness on the day of hCG administration on pregnancy outcome in the first fresh IVF\/ICSI cycle. Gynecol Endocrinol. 2016;32(6):473\u20136.","journal-title":"Gynecol Endocrinol"},{"issue":"11","key":"898_CR23","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1093\/humrep\/deg461","volume":"18","author":"P Kovacs","year":"2003","unstructured":"Kovacs P, Matyas S, Boda K, Kaali SG. The effect of endometrial thickness on IVF\/ICSI outcome. Hum Reprod. 2003;18(11):2337\u201341.","journal-title":"Hum Reprod"},{"issue":"12","key":"898_CR24","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1038\/nm.3012","volume":"18","author":"J Cha","year":"2012","unstructured":"Cha J, Sun X, Dey SK. Mechanisms of implantation: strategies for successful pregnancy. Nat Med. 2012;18(12):1754\u201367.","journal-title":"Nat Med"},{"issue":"3","key":"898_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nrg1808","volume":"7","author":"H Wang","year":"2006","unstructured":"Wang H, Dey SK. Roadmap to embryo implantation: clues from mouse models. Nat Rev Genet. 2006;7(3):185\u201399.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"898_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/humupd\/6.1.75","volume":"6","author":"H Taylor","year":"2000","unstructured":"Taylor H. The role of HOX genes in human implantation. Hum Reprod Update. 2000;6(1):75\u20139.","journal-title":"Hum Reprod Update"},{"key":"898_CR27","unstructured":"Adiguzel D, Celik-Ozenci C. FoxO1 is a cell-specific core transcription factor for endometrial remodeling and homeostasis during menstrual cycle and early pregnancy. Hum Reprod Update. 2021;27(3):570-583."},{"issue":"3","key":"898_CR28","first-page":"531","volume":"32","author":"L Whitaker","year":"2017","unstructured":"Whitaker L, Murray A, Matthews R, Shaw G, Williams A, Saunders P, et al. Selective progesterone receptor modulator (SPRM) ulipristal acetate (UPA) and its effects on the human endometrium. Human Reprod. 2017;32(3):531\u201343.","journal-title":"Human Reprod"},{"issue":"1","key":"898_CR29","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1096\/fj.11-184663","volume":"26","author":"Y Afshar","year":"2012","unstructured":"Afshar Y, Jeong J, Roqueiro D, DeMayo F, Lydon J, Radtke F, et al. Notch1 mediates uterine stromal differentiation and is critical for complete decidualization in the mouse. FASEB J. 2012;26(1):282\u201394.","journal-title":"FASEB J"},{"issue":"6","key":"898_CR30","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/labinvest.2014.57","volume":"94","author":"L Bergad\u00e0","year":"2014","unstructured":"Bergad\u00e0 L, Pallares J, Maria Vittoria A, Cardus A, Santacana M, Valls J, et al. Role of local bioactivation of vitamin D by CYP27A1 and CYP2R1 in the control of cell growth in normal endometrium and endometrial carcinoma. Laboratory Invest. 2014;94(6):608\u201322.","journal-title":"Laboratory Invest"},{"issue":"6","key":"898_CR31","doi-asserted-by":"publisher","first-page":"681 e681","DOI":"10.1016\/j.ajog.2014.06.030","volume":"211","author":"U Joneborg","year":"2014","unstructured":"Joneborg U, Eloranta S, Johansson AL, Marions L, Weibull CE, Lambe M. Hydatidiform mole and subsequent pregnancy outcome: a population-based cohort study. Am J Obstet Gynecol. 2014;211(6):681 e681\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"898_CR32","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1093\/humrep\/17.6.1610","volume":"17","author":"P Petignat","year":"2002","unstructured":"Petignat P, Vassilakos P, Campana A. Are fertility drugs a risk factor for persistent trophoblastic tumour? Hum Reprod. 2002;17(6):1610\u20135.","journal-title":"Hum Reprod"},{"issue":"1","key":"898_CR33","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ygyno.2015.11.014","volume":"140","author":"Y Eysbouts","year":"2016","unstructured":"Eysbouts Y, Bulten J, Ottevanger P, Thomas C, Ten Kate-Booij M, van Herwaarden A, et al. Trends in incidence for gestational trophoblastic disease over the last 20\u2009years in a population-based study. Gynecol Oncol. 2016;140(1):70\u20135.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"898_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4314\/ahs.v20i1.12","volume":"20","author":"A Zakaria","year":"2020","unstructured":"Zakaria A, Hemida R, Elrefaie W, Refaie E. Incidence and outcome of gestational trophoblastic disease in lower Egypt. Afr Health Sci. 2020;20(1):73\u201382.","journal-title":"Afr Health Sci"},{"issue":"8","key":"898_CR35","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1080\/0284186X.2018.1438653","volume":"57","author":"U Joneborg","year":"2018","unstructured":"Joneborg U, Folkvaljon Y, Papadogiannakis N, Lambe M, Marions L. Temporal trends in incidence and outcome of hydatidiform mole: a retrospective cohort study. Acta oncologica (Stockholm, Sweden). 2018;57(8):1094\u20139.","journal-title":"Acta oncologica (Stockholm, Sweden)"},{"issue":"1","key":"898_CR36","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12978-016-0181-5","volume":"13","author":"X Li","year":"2016","unstructured":"Li X, Du D, Chen S, Zheng S, Lee A, Chen Q. Trends in ectopic pregnancy, hydatidiform mole and miscarriage in the largest obstetrics and gynaecology hospital in China from 2003 to 2013. Reprod Health. 2016;13(1):58.","journal-title":"Reprod Health"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-022-00898-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-022-00898-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-022-00898-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T11:12:42Z","timestamp":1643973162000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-022-00898-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,4]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["898"],"URL":"https:\/\/doi.org\/10.1186\/s12958-022-00898-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-649509\/v1","asserted-by":"object"}]},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,4]]},"assertion":[{"value":"22 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Drum Tower Hospital, which is affiliated with the Nanjing University Medical School (no. 2021\u2013104-01). The ethics committees waived the requirement for informed consent due to the retrospective nature and anonymous data of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This manuscript has not been published or presented elsewhere and is not under consideration by another journal. All study participants provided informed consent and approved it for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}